Filing Details

Accession Number:
0001765581-24-000009
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 19:28:40
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 19:28:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2013156 L Philip Johnson 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Evp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2024-03-01 15,932 $0.00 15,932 No 4 A Direct
Ordinary Shares Acquisiton 2024-03-01 12,000 $119.65 27,932 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 P Direct
Footnotes
  1. These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2024, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.